Clinical outcomes of bcma car-t cells in a multiple myeloma patient with central nervous system invasion

HIGHLIGHTS

• who: Ting Wang and colleagues from the AORN Santobono-Pausilipon, Italy have published the research: Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion, in the Journal: (JOURNAL)
• what: This study reported an efficient and safe BCMA CAR-T_cell therapy for a CNS-MM patient with multiple severe extramedullary lesions. Meanwhile, the case in the study showed more severe cytogenetic abnormalities and extramedullary lesions in multiple organs. This study evaluated a BCMA CAR-T with CD28 and OX40 co-stimulatory domain that was different from the CAR . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.